Beneficial effect of platelet-activating factor antagonist TCV-309 on renal ischemia-reperfusion injury.
Yin
M
M
Department of Surgery, University Hospital Maastricht, The Netherlands.
Kurvers
H A
HA
Buurman
W A
WA
Tangelder
G J
GJ
Booster
M H
MH
Daemen
J H
JH
Kondracki
S
S
Kootstra
G
G
D000818:Animals; D003404:Creatinine / Q000097:blood; D007511:Ischemia / Q000473:pathology / Q000503:physiopathology; D007546:Isoquinolines / Q000494:pharmacology*; D007668:Kidney / Q000098:blood supply / Q000473:pathology / Q000502:physiology*; D008297:Male; D018715:Microscopy, Video; D009926:Organ Preservation; D010972:Platelet Activating Factor / Q000037:antagonists & inhibitors*; D011726:Pyridinium Compounds / Q000494:pharmacology*; D051381:Rats; D011917:Rats, Inbred Lew; D015427:Reperfusion Injury / Q000517:prevention & control*; D013696:Temperature; D044005:Tetrahydroisoquinolines
D007546:Isoquinolines; D010972:Platelet Activating Factor; D011726:Pyridinium Compounds; D044005:Tetrahydroisoquinolines; D003404:Creatinine; C067430:TCV 309